{
  "chapter": "Jirovecii",
  "questions": [
    {
      "q_no": 1,
      "question": "A clinician notes relative bradycardia in a patient with fever and respiratory symptoms. Which of the following infections is most commonly associated with relative bradycardia?",
      "options": {
        "A": "Brucellosis",
        "B": "Influenza",
        "C": "Streptococcal Pharyngitis",
        "D": "Tuberculosis"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Brucellosis Explanation: Relative bradycardia is where a person's pulse rate is lower than expected for their body temperature. Brucellosis, caused by Brucella melitensis , is associated with relative bradycardia due to the release of inflammatory cytokines and increased vagal tone, even in the presence of high fever. Causes of Relative Bradycardia in Infectious Diseases: Brucellosis Infection with Brucella melitensis leads to relative bradycardia due to inflammatory cytokines and increased vagal tone, despite high fever. COVID-19 Patients may exhibit relative bradycardia associated with myocardial injury and systemic inflammation, showing insufficient heart rate increase despite high fever and hypoxemia. Typhoid Fever Caused by Salmonella typhi , this infection is known for relative bradycardia, often alongside sustained fever and systemic symptoms. Legionnaire's Disease Linked to relative bradycardia, although the exact mechanisms are unclear. Chlamydial Pneumonia Can present with relative bradycardia as a clinical feature. Ebola Hemorrhagic Fever Noted in patients with Ebola, indicating its significance in severe viral infections. Influenza (Option B) typically does not present with relative bradycardia; due to its systemic effects, it often leads to tachycardia. Streptococcal Pharyngitis (Option C) is not associated with relative bradycardia; patients generally exhibit normal heart rates or tachycardia. Tuberculosis (Option D) can lead to various systemic symptoms but is not specifically linked to relative bradycardia. Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767972/ https://pmc.ncbi.nlm.nih.gov/articles/PMC7381903/ https://pubmed.ncbi.nlm.nih.gov/30048576/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10233606/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 2,
      "question": "A 28-year-old male presents with a history of fever, malaise, and abdominal discomfort. His temperature has been rising stepwise over the past five days. Physical examination reveals bradycardia and a faint rash on the abdomen. Blood cultures are positive for Salmonella typhi . Based on the diagnosis, what is the most likely fever pattern?",
      "options": {
        "A": "Intermittent fever",
        "B": "Remittent fever",
        "C": "Pel-Ebstein fever",
        "D": "Sustained fever"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Sustained fever Explanation: Sustained fever is characterized by a continuous elevated temperature that does not fluctuate significantly. It is commonly seen in typhoid fever, where the fever progressively rises in a stepwise manner over several days. Common Patterns of Fever: Fever Pattern Description Associated Conditions Fever Graph Sustained Fever Continuous elevated temperature. Typhoid fever, tuberculosis, bacterial pneumonia, neoplasms, connective tissue diseases Intermittent Fever Fever spikes followed by normal temperature. (Option A ruled out) Malaria, brucellosis Remittent Fever Fever fluctuates above normal without returning to baseline. (Option B ruled out) Various infectious diseases Hectic Fever High temperatures with wide fluctuations. Severe infections like bacteremia Pel-Ebstein Fever Weeks of high fevers followed by normal periods. (Option C ruled out) Hodgkin's disease Double Quotidian Fever Two fever spikes within 24 hours. Adult Still's disease, malaria Tertian Fever Fever occurs every third day. Malaria Quartan Fever Fever occurs every fourth day. Malaria Periodic Fever Syndromes Regular intervals of fever episodes. Cyclic neutropenia Specific Infections and Fever Patterns Infection Fever Pattern Description Malaria P. vivax / P. ovale : alternate days; P. malariae : every third day; P. falciparum : no specific pattern Dengue Continuous or \"saddle-back\" fever with breaks on days 4-5 Yellow Fever Recrudescence after initial resolution with back pain, jaundice Louse-borne Relapsing Fever Crisis after 4-10 days, profuse sweating, possible relapses Typhoid Fever Stepladder rise over 4-5 days with malaise and headaches",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 3,
      "question": "Which of the following statements about malarial fever is incorrect?",
      "options": {
        "A": "Quotidian fever is associated with P. falciparum infection .",
        "B": "Tertian fever occurs every 48 hours.",
        "C": "Quartan fever is linked to P. malariae.",
        "D": "Quotidian fever is associated with P. ovale."
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Quotidian fever is associated with P. ovale. Explanation: Quotidian fever refers to a fever pattern that occurs daily, returning to baseline each day and is typically associated with infections such as P. falciparum and P. knowlesi. Malaria fever patterns Type of Fever Characteristics Examples Quotidian Fever (Option A) Fever occurs once every day, and it will touch the baseline. P. falciparum, P. knowlesi Tertian Fever (Option B) Fever is occurring every 48 hours. P. vivax, P. ovale Quartan Fever (Option C) Fever will occur after every 72 hours. P. malariae Reference: www.ncbi.nlm.nih.gov/books/NBK8584/#:~:text=The%20most%20characteristic%20symptom%20of,irr egular%2C%20showing%20no%20distinct%20periodicity.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 4,
      "question": "A 55-year-old male presents to the emergency department with a fever of 38.5°C (101.3°F) that has persisted for three weeks. He reports significant weight loss, night sweats, and fatigue. His medical history is unremarkable. On physical examination, he has splenomegaly and mild lymphadenopathy. Which investigation would be the most appropriate next step in this patient's management?",
      "options": {
        "A": "Chest X-ray",
        "B": "Blood culture",
        "C": "CT scan of the abdomen and pelvis",
        "D": "HIV test"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) CT scan of the abdomen and pelvis Explanation: Given the patient's symptoms of prolonged fever, significant weight loss, night sweats, splenomegaly, and lymphadenopathy, a CT scan can help identify potential underlying causes such as infections, malignancies (e.g., lymphomas), or abscesses. It provides a comprehensive view of the abdominal organs and lymphatic structures. PUO-causes Category Common Causes Other Causes Infections Tuberculosis (military or disseminated / extra-pulmonary) Endocarditis (culture negative) Deep-seated infections (abscesses, prostatitis, etc.) Typhoidal and non-typhoidal Salmonella Emerging Infections: HIV, Leishmaniasis, Melioidosis Travelers: Malaria, Visceral leishmaniasis, Histoplasmosis Neoplasms Malignant lymphomas Renal-cell carcinoma, hepatocellular cancer Ovarian cancer, atrial myxoma Castleman disease, brain tumors Auto-inflammatory and Autoimmune Disorders Giant-cell arteritis, Polymyalgia rheumatica (elderly) Adult-onset Still's disease (younger) Inflammatory bowel disease, certain types of uveitis, Behçet's syndrome Rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, polymyositis PAN, small vessel vasculitis, FMF Miscellaneous Granulomatous: Kikuchi disease, Sarcoidosis, Granulomatous hepatitis Vascular: atrial myxoma, pulmonary emboli, hematomas Endocrine: thyrotoxicosis, thyroiditis, Pheochromocytoma Hematologic: HUS, TTP Cirrhosis, Pancreatitis, Factitious fever Drug fever (3-7% of febrile episodes in hospitalized patients; 1/3 due to antibiotics - beta-lactams) DRESS, Hyperthermic drug syndromes (NMS, Serotonin syndrome) Two stages of baseline tests followed by more specific tests, after which each abnormal result should be weighed carefully: Two Stages of Baseline Tests Baseline Set of Investigations: Blood count with a differential cell count Renal electrolytes and liver function tests C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) Clotting screen Creatine kinase At least two blood cultures (while not receiving antibiotics) HIV test Chest X-ray Ultrasound of the abdomen Urine dipstick Second-Line Investigations: Microbiological tests Imaging Biopsies Note: Early blanket testing for all possible aetiologies is inappropriate. Each abnormal result should be weighed carefully. Chest X-ray (Option A): Limited to evaluating respiratory causes and may miss abdominal pathologies. Blood cultures (Option B) are important for detecting infections but may not identify structural causes of the patient's symptoms. HIV test (Option D): Relevant for considering infectious etiologies but does not provide immediate insights into potential underlying structural abnormalities. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Pages 219, 220",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 5,
      "question": "Which of the following is not considered an autoinflammatory syndrome?",
      "options": {
        "A": "Familial Mediterranean fever",
        "B": "Adult-onset Still's disease",
        "C": "Rheumatoid arthritis",
        "D": "Cryopyrin-associated periodic syndromes"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Rheumatoid arthritis Explanation: Rheumatoid arthritis is classified as an autoimmune disease, not an autoinflammatory syndrome. Familial Mediterranean fever , Adult-onset Still’s disease , and Cryopyrin-associated periodic syndromes , are recognized as autoinflammatory syndromes. (Option A, B, D) Non-infectious Inflammatory Disorder Category Examples Systemic Rheumatic and Autoimmune Diseases Ankylosing spondylitis Behçet's disease Mixed connective-tissue disease Rheumatoid arthritis Sjögren's syndrome SLE Vogt-Koyanagi-Harada syndrome(VKH Syndrome) Vasculitis Allergic vasculitis Eosinophilic granulomatosis with polyangiitis Giant cell vasculitis/polymyalgia rheumatica Granulomatosis with polyangiitis Kawasaki disease Polyarteritis nodosa Takayasu arteritis Granulomatous Diseases Idiopathic granulomatous hepatitis, sarcoidosis Autoinflammatory Syndromes (Option A, B, and D ruled out) Adult-onset Still's disease CAPS (cryopyrin-associated periodic syndromes) Familial Mediterranean fever Hyper-IgD syndrome (HIDS, also known as mevalonate kinase deficiency) PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis) SAPHO (synovitis, acne, pustulosis, hyperostosis, osteomyelitis) TRAPS (tumor necrosis factor receptor-associated periodic syndrome) Reference: https://www.jwatch.org/id200609060000005/2006/09/06/fuo-noninfectious-inflammatory-disorders",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 6,
      "question": "A 30-year-old female presents with a fever of 39°C that has persisted for the past five days. She reports severe muscle pain, nausea, and retroorbital pain. On examination, she has mild dehydration and a positive tourniquet test. Which of the following investigations would be most appropriate to confirm the diagnosis?",
      "options": {
        "A": "Complete blood count",
        "B": "NS-1 Antigen test",
        "C": "Blood culture",
        "D": "Liver function tests"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) NS-1 Antigen test Explanation: This is a case of Dengue The NS-1 antigen test is specific for dengue and can be positive as early as Day 1 of infection. Diagnostic criteria: Fever: Must be present. Any 2 of the following 6 features: Retroorbital pain, myalgia, or \"break-bone fever\" Protracted nausea or vomiting: Can lead to dehydration Rash: Observed during the illness Warning signs: Any 1 positive sign (e.g., severe abdominal pain, persistent vomiting) Positive tourniquet test: >20 petechiae per square inch BP cuff inflated between systolic and diastolic blood pressure The cuff inflated for 5 minutes Leucopenia: Decreased white blood cell count Investigations Test Type Description ELISA IgM dengue virus (MAC-ELISA) Positive by Day 4 of infection Indicates recent infection NAAT Detects viral RNA Useful for early diagnosis NS-1 Antigen NS-1 (IgG) Positive on Day 1 of infection Should be performed within 7 days of symptom onset Complete blood count (Option A): While helpful in assessing leukopenia and thrombocytopenia, it does not confirm dengue. Blood culture (Option C): This is more relevant for bacterial infections and is not specific for viral infections like dengue. Chest X-ray (Option D): Not relevant in this context as it doesn't help diagnose dengue. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 244",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 7,
      "question": "A 38-year-old male presents with a one-week history of fever, headache, retro-orbital pain, and myalgia. Skin examination reveals multiple purpura and petechiae on the left shoulder, trunk, and legs. Similar cases have been reported linked to increased incidence of mosquito breeding. What is the most common neurological complication associated with this condition?",
      "options": {
        "A": "Encephalopathy",
        "B": "Guillain-Barré Syndrome",
        "C": "Stroke",
        "D": "Encephalitis"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Encephalopathy Explanation: The clinical presentation including fever, headache, retro-orbital pain, myalgia, and the presence of purpura and petechiae, suggests a viral infection consistent with dengue fever. The association with increased mosquito breeding further supports this diagnosis. Encephalopathy is the most common neurological complication associated with this condition. Dengue complications Neurological Dengue encephalopathy is most commonly encountered neurological complication of dengue virus (Option A) linked primarily to dengue hemorrhagic fever and dengue shock syndrome EEG may show abnormalities such as burst suppression and seizures CSF profiles typically remain normal. Neuroimaging can be normal or reveal diffuse cerebral edema. Encephalitis (Option D ruled out) GBS (Option B ruled out) Stroke (Option C ruled out) Cardiomyopathy Dengue virus-induced dilated cardiomyopathy should always be considered if a dengue fever patient has refractory shock and signs and symptoms of congestive heart failure. Hepatic injury Liver involvement in dengue is a crucial feature The effect ranges from an asymptomatic rise in liver enzymes to the development of ALF The most common atypical manifestation reported was hepatitis Pneumonia Staphylococcus pneumonia is an important accompanying problem seen in dengue patient co-infection between dengue and influenza can result in exacerbation of pneumonia Orchitis Orchitis usually occurs together with epididymitis Commonly seen in men between 14 and 35 years of age. Dengue Hemorrhagic Fever All of the following: Acute onset of fever 2-7 days duration Hemorrhagic manifestations Positive tourniquet test/Petechiae Ecchymosis Purpura/Bleeding from mucosa, GIT, Injection sites, etc Platelet count ≤ 100,000 cells/cu.mm. Plasma leakage Rising hematocrit Hemoconcentration >20% Pleural effusion, ascites/Hypoproteinemia) Dengue Shock Syndrome DHF criteria plus Signs of Shock Tachycardia/Cool extremities/Weak pulse/Lethargy/Restlessness Pulse pressure <20 mm Hg with increased Diastolic pressure (e.g. 100/80) Hypotension (Systolic <80 mm Hg for age <5 years/80-90 mm Hg for older child and adults) Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 243 https://link.springer.com/article/10.1007/s11910-022-01213-7 https://journals.lww.com/annals-of-medicine-and-sur gery/fulltext/2023/02000/acute_liver_failure_in_a_young_patient_with_dengue.46.aspx#:~:text=Hepatic%20encep halopathy%20is%20usually%20corrected,prevent%20hepatotoxic%20injury23%2C24. https://symbiosisonlinepublishing.com/pulmonology-infectious-diseases/pulmonology-infectious-diseases10.php http s://pmc.ncbi.nlm.nih.gov/articles/PMC4352732/#:~:text=Dengue%20fever%20can%20have%20varied,antivirals% 2C%20immunosuppressants%2C%20and%20steroids. https://journals.lww.com/kleu/fulltext/2016/09030/dengue_fever_presenting_as_epididymo_orchitis.15.aspx",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 8,
      "question": "A 28-year-old female presents with a fever of 39°C for the past three days. She reports muscle aches and mild retro-orbital pain but denies any gastrointestinal symptoms. On examination, she is alert, has a dry mouth, and a rash on her trunk, and her vital signs are stable. She has passed urine twice in the last six hours. Which of the following treatments is most appropriate for her management?",
      "options": {
        "A": "Start intravenous fluids",
        "B": "Administer ORS and paracetamol",
        "C": "Prescribe aspirin for fever",
        "D": "Admit to the hospital for observation"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Administer ORS and paracetamol Explanation: This case is suggestive of dengue fever, given the presentation of high fever, muscle aches, retro-orbital pain, and rash. Given that the patient has no warning signs, is stable, and can tolerate oral fluids, she falls into the outpatient management category. The appropriate treatment includes: ORS (Oral Rehydration Solution) to address mild dehydration. Paracetamol for fever control, while avoiding aspirin due to its bleeding risk in potential dengue cases. Treatment: Group A (Outpatient) No warning signs: Abdominal pain or tenderness Persistent vomiting Clinical fluid accumulation Mucosal bleed Lethargy or restlessness Liver enlargement > 2 cm Hematocrit count Rise >20% admission value Rapid decrease in platelet count And who are able to: Tolerate adequate volumes of oral fluids To pass urine at least once every 6 hours Treatment Plenty of fluids- ORS, coconut water (avoid excess plain water) Paracetamol(500-650 mg per dose) for high fever Dosing should not be less than six hours Tepid sponge if the patient still has high fever Don't take: aspirin, ibuprofen, diclofenac or mefenamic acid (Option C ruled out) Report to hospital immediately if Bleeding Vomiting Severe abdomen pain Drowsiness Breathing difficulty Not passing urine > 6 hours Group B (Inpatient) Warning signs present or Coexisting: Pregnancy, infancy, old age Obesity, diabetes mellitus, renal failure Chronic hemolytic diseases or Social: Living alone or living far from a health facility without reliable means of transport Dengue GROUP (B)\" data-author=\"NA\" data-hash=\"8501\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"625\" src=\"https://image.prepladder.com/notes/1qshjXRP86UcXAEdMBkg1744285658.png\" width=\"600\" /> Note: Group C (ICU) For Hemodynamically unstable Dengue IV fluids and Hospital admission (Options A and D) are not necessary given her stable condition and the absence of severe symptoms. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 244",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 9,
      "question": "A 35-year-old male presents to the hospital with fever, muscle aches, vomiting, and respiratory distress after consuming contaminated palm sap in a region known for bat activity. Laboratory tests reveal elevated white blood cell counts in his cerebrospinal fluid. Based on the clinical presentation and diagnostic findings, which of the following statements regarding Nipah virus infection is correct? for Nipah virus.",
      "options": {
        "A": "The virus is primarily transmitted from human to human through respiratory droplets.",
        "B": "Supportive care is the mainstay of treatment, as there are no approved antiviral therapies specifically",
        "C": "The incubation period for Nipah virus infection is usually less than 4 days.",
        "D": "Ribavirin is the first-line antiviral treatment with established efficacy in humans."
      },
      "correct_answer": "B",
      "explanation": "therapies specifically for Nipah virus. Correct Answer: B) Supportive care is the mainstay of treatment, as there are no approved antiviral therapies specifically for Nipah virus. Explanation: Nipah virus infection currently lacks approved antiviral treatments, making supportive care crucial for managing symptoms and complications. This includes maintaining vital functions, hydration, and monitoring. While some agents like Ribavirin have been used, their effectiveness is not well-established, reinforcing the importance of supportive management in treating affected patients. Nipah Virus Features Transmission Primarily from bats (natural reservoir) to humans (Option A ruled out) Intermediate hosts: pigs Contaminated food products (e.g., palm sap) Human-to-human transmission through infected bodily fluids Clinical Presentation Incubation: 4 to 45 days (Option C ruled out) Symptoms: Fever Muscle aches Vomiting Respiratory distress Neurological symptoms (e.g., seizures, altered consciousness, encephalitis) Pathophysiology Infects respiratory epithelium Can cause acute respiratory distress syndrome (ARDS) May affect multiple organs, leading to multi-organ failure Diagnostic Workup: Diagnostic Method Description Laboratory Tests PCR for viral RNA detection ELISA for IgM and IgG antibodies CSF analysis for elevated WBC or protein levels Imaging Studies MRI or CT scans to assess neurological involvement (not specific for NiV) Treatment Options Supportive Care Maintain airway patency Ensure fluid and electrolyte balance Monitor vital signs Intensive care for severe cases Antiviral Agents Agent Notes Ribavirin Mixed results; efficacy remains controversial (Option D ruled out) m102.4 Monoclonal antibody, promising in animal studies, used compassionately in humans Favipiravir Under investigation, requires further validation Remdesivir Under investigation, requires further validation Preventive Measures Avoid exposure to bats and pigs Strict infection control during outbreaks Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 247 https://www.ncbi.nlm.nih.gov/books/NBK570576/ https://pmc.ncbi.nlm.nih.gov/articles/PMC8483238/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576574/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 10,
      "question": "A 28-year-old woman presents with fever, conjunctivitis, and a maculopapular rash after returning from a trip to Central America. Her clinical presentation is suggestive of Zika virus infection. Which of the following statements about Zika virus (ZIKV) is true?",
      "options": {
        "A": "Transmitted only through infected bodily fluids.",
        "B": "Incubation period is 1 to 3 days.",
        "C": "Complications include microcephaly and Guillain–Barré syndrome.",
        "D": "Reliable diagnosis via serology in the first week."
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Complications include microcephaly and Guillain–Barré syndrome. Explanation: Zika virus (ZIKV) infection can lead to serious complications such as congenital microcephaly in newborns and Guillain–Barré syndrome in adults. \\ The virus is primarily transmitted through mosquito bites and sexual contact, with an incubation period of 3–12 days, making option C the only correct statement. Zika Virus Transmission: (Option A ruled out) Spread by Aedes aegypti and Aedes albopictus mosquitoes (daytime feeders). Sexual transmission is possible. Epidemiology: Initially identified in Africa and Asia. It has become an epidemic in the Caribbean and Central/South America since 2015. Clinical features of ZIKA Infection Feature Description Incubation period 3–12 days (Option B ruled out) Symptomatic presentation Fever, arthralgia, conjunctivitis, maculopapular rash Possible complications Guillain–Barré syndrome Congenital microcephaly Other congenital issues Cerebral calcification Deafness Vision problems Joint contractures (arthrogryposis) Hydrops fetalis Growth retardation Infection target Neural progenitor cells Workup for ZIKV Infection Test Type Findings Routine blood tests Possible leucopenia, thrombocytopenia, or elevated transaminases (often normal) PCR test Detects ZIKV in blood (first week) or urine (up to 14 days) Serology Retrospective diagnosis; cross-reactivity with other flaviviruses (Option D ruled out) Plaque-reduction neutralisation testing Detects virus-specific neutralising antibodies to differentiate primary infections. Treatment of ZIKV Infection Approach: Supportive care (specifics not detailed). Prevention of ZIKV Infection Prevention Method Recommendations Mosquito bite prevention Primary method to avoid infection Sexual health precautions Infected individuals: safe sex for 6 months Delay pregnancy for 6 months Asymptomatic travelers Safe sex and avoid pregnancy for 2 months after returning Vaccination status No vaccine currently available",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 11,
      "question": "A 32-year-old male presents with progressive bilateral lower limb weakness over the past 10 days. On examination, he has flaccid paralysis and absent deep tendon reflexes in the affected limbs. Cerebrospinal fluid (CSF) analysis reveals a normal white cell count with elevated protein levels. Nerve conduction studies confirm a demyelinating pattern. Based on the Brighton criteria, which level of diagnostic certainty for Guillain-Barré syndrome (GBS) does this patient fulfill?",
      "options": {
        "A": "Level 1",
        "B": "Level 2",
        "C": "Level 3",
        "D": "Level 4"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Level 1 Explanation: Level 1 criteria are fulfilled since: There is bilateral flaccid weakness . Absent deep tendon reflexes are noted. Monophasic course with progressive symptoms within a defined time frame. CSF findings are consistent with albuminocytological dissociation (elevated protein with normal white cell count). Nerve conduction study (NCS) is supportive of GBS. Brighton Criteria Levels of Diagnostic Certainty The Brighton criteria classify GBS diagnosis into four levels based on clinical and laboratory findings: Level Criteria Level 1 No alternative diagnosis for weakness Diminished/absent deep tendon reflexes in weak limbs Monophasic course: onset to nadir within 12 hours to 28 days Bilateral flaccid limb weakness CSF cell count < 50 cells/microlitre Elevated CSF protein concentration Nerve conduction study (NCS) consistent with GBS subtype Level 2 All Level 1 criteria met, with possible variations (e.g., present reflexes in some cases). (Option B ruled out) Level 3 Most Level 1 criteria met but lacking one or more key features. (Option C ruled out) Level 4 Minimal criteria were met; these may include atypical or incomplete presentations. (Option D ruled out) Sensitivity of the Brighton Criteria Level 1 : ~72% Level 2 : ~96% Level 3 : ~98% Clinical features aligning with the Brighton criteria include : Symmetrical limb weakness : Bilateral weakness is common. Diminished reflexes : Often absent or reduced in affected limbs. Monophasic course : Rapid progression, peaking within weeks. Cerebrospinal fluid (CSF) analysis : Typically shows albuminocytological dissociation (elevated protein with normal white cell count). Reference: https://pubmed.ncbi.nlm.nih.gov/32511817/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320636/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 12,
      "question": "A 40-year-old HIV-positive patient presents with fever, dry cough, and progressive shortness of breath. His CD4+ count is 150 cells/mm³. Chest X-ray shows bilateral interstitial infiltrates. Which of the following is the most likely mechanism of infection in this patient?",
      "options": {
        "A": "Primary infection acquired from a contaminated water source",
        "B": "Airborne transmission from an infected individual",
        "C": "Ingestion of fungal spores from environmental reservoirs",
        "D": "Reactivation of a previously dormant infection acquired during childhood"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Airborne transmission from an infected individual Explanation: This patient with HIV and a low CD4+ count (150 cells/mm³), fever, dry cough, and bilateral interstitial infiltrates on chest X-ray likely has Pneumocystis jirovecii pneumonia (PJP) . PJP is a common opportunistic infection in immunocompromised individuals and is primarily transmitted via airborne spread from person to person. The organism is inhaled, leading to infection in the lungs, especially when immune defenses are weakened. Pneumocystis Jiroveci\" data-author=\"NA\" data-hash=\"8503\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"700\" src=\"https://image.prepladder.com/notes/irqydppR4US7erO9JzRL1744285919.png\" width=\"700\" /> Pneumocystis jirovecii: Cause and Transmission Opportunistic Pathogen : Primarily affects immunocompromised individuals (e.g., HIV/AIDS patients with CD4+ counts <200 cells/mm³). Colonization in Healthy Individuals : Common in healthy lungs; most children are exposed by age 4. Reactivation in adults is possible from childhood exposure or new infections. Airborne Transmission : Spreads through person-to-person contact, especially in hospital settings. Colonized individuals exhale the organism, contaminating the environment. Reinfection vs. Reactivation : Both reinfection with new strains and reactivation of dormant infection are possible causes of recurrent PCP. Environmental Reservoir : Exact environmental source unknown, but the organism has been found in air samples near infected patients. Primary infection acquired from a contaminated water source (Option A): Pneumocystis jirovecii is not transmitted through water sources. Ingestion of fungal spores from environmental reservoirs (Option C) : There is no evidence suggesting transmission through ingestion of spores. Reactivation of a previously dormant infection acquired during childhood (Option D) : Partially correct but not the best answer. Although reactivation can occur, the question hints at new infection rather than reactivation. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Pages 220, 224 https://pmc.ncbi.nlm.nih.gov/articles/PMC4536784/ https://pmc.ncbi.nlm.nih.gov/articles/PMC9696632/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 13,
      "question": "A 45-year-old male with HIV presents with low-grade fever, nonproductive cough, and progressive shortness of breath over the past month. His HRCT shows bilateral ground-glass opacities. Which of the following statements correctly differentiates PCP in HIV-infected patients from non-HIV individuals? initially.",
      "options": {
        "A": "PCP in HIV-infected patients usually present with acute onset and severe oxygenation impairment.",
        "B": "Non-HIV patients with PCP experience a gradual onset with mild respiratory distress.",
        "C": "HIV-infected individuals typically have a chronic presentation with milder respiratory distress",
        "D": "Mortality in HIV-infected PCP cases is higher (30-60%) compared to non-HIV individuals."
      },
      "correct_answer": "C",
      "explanation": "respiratory distress initially. Correct Answer: C) HIV-infected individuals typically have a chronic presentation with milder respiratory distress initially. Explanation: In HIV-infected patients, PCP develops gradually over weeks to months with initially milder respiratory distress due to partial immune function, allowing a slower progression. In contrast, non-HIV patients experience acute onset and rapid respiratory decline, often leading to severe hypoxemia and higher mortality. Pneumocystis Jirovecii Pneumonia (PCP) PCP is a major opportunistic infection in immunocompromised individuals, with varying symptoms based on immune status (HIV vs. non-HIV). Clinical Features of PCP General Symptoms Fever Nonproductive cough Dyspnea (shortness of breath) Tachypnea (rapid breathing) Symptom Variations by Immune Status Parameter HIV-Infected Patients Non-HIV Patients Onset Gradual (2 weeks to 2 months) (Option A ruled out) Sudden (within a week) (Option B ruled out) Symptom Severity Milder respiratory distress initially Rapid progression to respiratory failure (Option B ruled out) Course Chronic Acute Oxygen Impairment Less severe (Option A ruled out) More severe Physical examination findings Normal lung sounds despite hypoxemia Signs of respiratory distress : Nasal flaring and retractions (in infants or severely affected adults) Radiological findings HRCT : Bilateral interstitial pneumonia Ground-glass opacities and patchy consolidations Prognosis Group Mortality Rate Non-HIV Patients 30%–60% (Option D ruled out) HIV-Infected Patients 10%–20% Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 224 https://pmc.ncbi.nlm.nih.gov/articles/PMC9696632/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 14,
      "question": "A 35-year-old immunocompromised patient presents with a persistent cough, dyspnea, and fever. A chest X-ray shows bilateral infiltrates. Sputum examination is inconclusive, and a bronchoalveolar lavage (BAL) is performed. Which of the following diagnostic methods is most likely to provide the highest sensitivity for confirming the presence of Pneumocystis jirovecii ? D. β",
      "options": {
        "A": "Induced sputum microscopy",
        "B": "Chest X-ray",
        "C": "Polymerase Chain Reaction (PCR)",
        "D": "glucan assay"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Polymerase Chain Reaction (PCR) Explanation: PCR is a highly sensitive method for detecting Pneumocystis jirovecii DNA, with sensitivity rates up to 96%. It is preferred over other methods, such as induced sputum microscopy or chest X-rays, which have lower sensitivity and may yield inconclusive results. This high accuracy is crucial for diagnosing PCP, especially in immunocompromised patients. Investigations for Pneumocystis Jirovecii Pneumonia Clinical Assessment (History and Symptoms ): Focus on respiratory symptoms: cough, dyspnea, fever. Particularly important for immunocompromised patients. Imaging Studies Type Findings Chest X-ray Bilateral infiltrates, ground-glass opacities. (Option B ruled out) CT Scan More sensitive; shows ground-glass opacities, cystic lesions. Laboratory Tests Sputum Examination Induced Sputum : Collected post-saline inhalation; stained (e.g., Grocott methenamine silver stain) for microscopy. (Option A ruled out) Bronchoalveolar Lavage (BAL) Procedure : Saline washing of bronchi for fluid analysis. Staining and Microscopy : Visualizes Pneumocystis jirovecii cysts in BAL fluid. Molecular Methods PCR : Highly sensitive; detects Pneumocystis jirovecii DNA. Sensitivity up to 96%, specificity around 98%. Real-time PCR preferred over nested PCR for efficiency. LAMP : Rapid detection method for Pneumocystis . Serological Tests β -D-glucan Assay : Indicates fungal infections; helps differentiate between colonization and active infection. (Option D ruled out) Challenges in Diagnosis Traditional staining methods show low sensitivity. Presence of Pneumocystis jirovecii DNA may indicate colonization rather than active infection.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    },
    {
      "q_no": 15,
      "question": "A 35-year-old male patient with a history of HIV presents with worsening dyspnea and a dry cough. A chest X-ray reveals bilateral infiltrates, and a diagnosis of Pneumocystis jirovecii pneumonia (PCP) is made. Which of the following is the first-line treatment for this condition?",
      "options": {
        "A": "Pentamidine",
        "B": "Trimethoprim/Sulfamethoxazole (TMP/SMX)",
        "C": "Atovaquone",
        "D": "Clindamycin with Primaquine"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Trimethoprim/Sulfamethoxazole (TMP/SMX) Explanation: The first-line treatment for Pneumocystis jirovecii pneumonia (PCP) is Trimethoprim/Sulfamethoxazole (TMP/SMX) due to its high efficacy against both mild and severe cases. Alternatives like Pentamidine and Atovaquone are reserved for patients intolerant to TMP/SMX or with milder disease. Therefore, TMP/SMX remains the preferred choice in clinical practice. Treatment of Pneumocystis Jiroveci First-Line Treatment: Trimethoprim/Sulfamethoxazole (TMP/SMX) Dosage : Intravenous (IV) : TMP: 15-20 mg/kg/day SMX: 75-100 mg/kg/day Administered every 6-8 hours Oral : Switch to oral TMP/SMX after clinical improvement at similar dosages. Duration : 21 days Efficacy : First-line treatment for both mild and severe PCP. Alternative Treatments Treatment Administration Indication Pentamidine IV: 4 mg/kg/day For patients intolerant to TMP/SMX (Option A ruled out) Atovaquone Oral: 750 mg twice daily Effective for mild to moderate PCP, fewer side effects (Option C ruled out) Clindamycin + Primaquine Combination therapy For patients failing TMP/SMX or pentamidine (Option D ruled out) Dapsone Alone or with TMP For prophylaxis and treatment in select cases Caspofungin Combination with low-dose TMP/SMX For severe cases Adjunctive Therapy Corticosteroids : Recommended for moderate to severe PCP, especially with low oxygen levels (PaO2 < 70 mm Hg or oxygen saturation < 92%) . Regimen : Prednisone, starting with high doses, tapering over days. Reference: Davidson’s Principles and Practice of Medicine, 24th Edition, Page 224 https://pmc.ncbi.nlm.nih.gov/articles/PMC10038753/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Jirovecii"
    }
  ]
}
